BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24329105)

  • 1. Histopathological analysis and clinical correlation of drug reaction with eosinophilia and systemic symptoms (DRESS).
    Chi MH; Hui RC; Yang CH; Lin JY; Lin YT; Ho HC; Chung WH; Kuo TT
    Br J Dermatol; 2014 Apr; 170(4):866-73. PubMed ID: 24329105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative histological analysis of drug-induced maculopapular exanthema and DRESS.
    Skowron F; Bensaid B; Balme B; Depaepe L; Kanitakis J; Nosbaum A; Maucort-Boulch D; Bérard F; D'Incan M; Kardaun SH; Nicolas JF
    J Eur Acad Dermatol Venereol; 2016 Dec; 30(12):2085-2090. PubMed ID: 27422093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathologic spectrum of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): a diagnosis that needs clinico-pathological correlation.
    Borroni G; Torti S; Pezzini C; Vassallo C; Rosso R; D'Ospina RM; Tomasini C; Brazzelli V
    G Ital Dermatol Venereol; 2014 Jun; 149(3):291-300. PubMed ID: 24819756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overlap between maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms among cutaneous adverse drug reactions in a dermatology ward.
    Pinto Gouveia M; Gameiro A; Coutinho I; Pereira N; Cardoso JC; Gonçalo M
    Br J Dermatol; 2016 Dec; 175(6):1274-1283. PubMed ID: 27128886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases.
    Skowron F; Bensaid B; Balme B; Depaepe L; Kanitakis J; Nosbaum A; Maucort-Boulch D; Bérard F; D'Incan M; Kardaun SH; Nicolas JF
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2199-205. PubMed ID: 26354734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological Characterization of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) and Comparison with Maculopapular Drug Rash (MPDR).
    Jindal R; Chugh R; Chauhan P; Shirazi N; Bisht YS
    Indian Dermatol Online J; 2022; 13(1):32-39. PubMed ID: 35198465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug reaction with eosinophilia and systemic symptoms (DRESS): A histopathology based analysis.
    Sasidharanpillai S; Govindan A; Riyaz N; Binitha MP; Muhammed K; Khader A; Reena Mariyath OK; Simin M; Subin K
    Indian J Dermatol Venereol Leprol; 2016; 82(1):28-36. PubMed ID: 26728807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study.
    Ortonne N; Valeyrie-Allanore L; Bastuji-Garin S; Wechsler J; de Feraudy S; Duong TA; Delfau-Larue MH; Chosidow O; Wolkenstein P; Roujeau JC
    Br J Dermatol; 2015 Jul; 173(1):50-8. PubMed ID: 25630796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases.
    Walsh S; Diaz-Cano S; Higgins E; Morris-Jones R; Bashir S; Bernal W; Creamer D
    Br J Dermatol; 2013 Feb; 168(2):391-401. PubMed ID: 23034060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: clinical features of 27 patients.
    Avancini J; Maragno L; Santi CG; Criado PR
    Clin Exp Dermatol; 2015 Dec; 40(8):851-9. PubMed ID: 26271788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-existence of histopathological features is characteristic in drug reaction with eosinophilia and systemic symptoms and correlates with high grades of cutaneous abnormalities.
    Cho YT; Liau JY; Chang CY; Yang CW; Chen KL; Chen YC; Song HL; Chu CY
    J Eur Acad Dermatol Venereol; 2016 Dec; 30(12):2077-2084. PubMed ID: 27225695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathology of the Exanthema in DRESS Is Not Specific but May Indicate Severity of Systemic Involvement.
    Gonçalo MM; Cardoso JC; Gouveia MP; Coutinho I; Gameiro AR; Brites MM; Tellechea ÓE
    Am J Dermatopathol; 2016 Jun; 38(6):423-33. PubMed ID: 26630685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological study of six types of adverse cutaneous drug reactions using granulysin expression.
    Weinborn M; Barbaud A; Truchetet F; Beurey P; Germain L; Cribier B
    Int J Dermatol; 2016 Nov; 55(11):1225-1233. PubMed ID: 27421110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study.
    Kardaun SH; Sekula P; Valeyrie-Allanore L; Liss Y; Chu CY; Creamer D; Sidoroff A; Naldi L; Mockenhaupt M; Roujeau JC;
    Br J Dermatol; 2013 Nov; 169(5):1071-80. PubMed ID: 23855313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the complexities of drug reaction with eosinophilia and systemic symptoms (DRESS): Insights into clinical, laboratory, and histopathologic features of a case series from an Italian tertiary center.
    Schroeder JW; Napoli C; Caputo V; Bonoldi E; Rongioletti F
    Clin Dermatol; 2023; 41(6):721-728. PubMed ID: 37730074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand.
    Hiransuthikul A; Rattananupong T; Klaewsongkram J; Rerknimitr P; Pongprutthipan M; Ruxrungtham K
    Allergol Int; 2016 Oct; 65(4):432-438. PubMed ID: 27134114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interface dermatitis as an indicator of hepatic involvement in drug reaction with eosinophilia and systemic symptoms (DRESS).
    Sasidharanpillai S; Govindan A; Ajithkumar K; Chathoth AT; Khader A; Reena Mariyath OK; Farsha R; Sherin N; David EM
    J Cutan Pathol; 2020 Sep; 47(9):800-808. PubMed ID: 32310304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RegiSCAR DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) Validation Scoring System and Japanese Consensus Group Criteria for Atypical Drug-Induced Hypersensitivity Syndrome (DiHS): A Comparative Analysis.
    Sasidharanpillai S; Ajithkumar K; Jishna P; Khader A; Anagha KV; Binitha MP; Chathoth AT
    Indian Dermatol Online J; 2022; 13(1):40-45. PubMed ID: 35198466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistopathological Findings of Severe Cutaneous Adverse Drug Reactions.
    Orime M
    J Immunol Res; 2017; 2017():6928363. PubMed ID: 29226159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic management of DRESS: a retrospective study of 38 cases.
    Funck-Brentano E; Duong TA; Bouvresse S; Bagot M; Wolkenstein P; Roujeau JC; Chosidow O; Valeyrie-Allanore L
    J Am Acad Dermatol; 2015 Feb; 72(2):246-52. PubMed ID: 25592341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.